Drug Dosage in Patients during Continuous Renal Replacement Therapy
- 1 May 1993
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 24 (5) , 362-379
- https://doi.org/10.2165/00003088-199324050-00002
Abstract
The advantages of continuous haemofiltration and haemodialysis over intermittent haemodialysis for the treatment of acute renal failure are well recognised. In intensive care patients, 4 different...Keywords
This publication has 97 references indexed in Scilit:
- Clinical Pharmacokinetics of Antibiotics in Patients with Impaired Renal FunctionClinical Pharmacokinetics, 1992
- Pharmacokinetics of Cefuroxime and Ceftazidime in Patients with Acute Renal Failure Treated by Continuous Arteriovenous HaemodialysisNephrology Dialysis Transplantation, 1991
- Pharmacokinetics of Imipenem/Cilastatin during Continuous Arteriovenous HemofiltrationPublished by S. Karger AG ,1990
- Norepinephrine clearance, chromogranin A and dopamine β hydroxylase in renal failureKidney International, 1990
- Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysisEuropean Journal of Clinical Pharmacology, 1987
- Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysisEuropean Journal of Clinical Pharmacology, 1987
- Continuous Arteriovenous Hemofiltration of Aminoglycoside Antibiotics in Critically Ill PatientsThe Journal of Clinical Pharmacology, 1986
- Elimination kinetics of captopril in patients with renal failureKidney International, 1984
- Drug Prescribing in Renal Failure: Dosing Guidelines for AdultsAmerican Journal of Kidney Diseases, 1983
- The metabolic disposition of flucloxacillin in patients with impaired kidney functionEuropean Journal of Clinical Pharmacology, 1982